APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat
Public ClinicalTrials.gov record NCT00242281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicenter Study to Evaluate the Safety/Efficacy of APC-111 MP Tablet QD vs. Penicillin VK QID Both for 10 Days Treatment of Pharyngitis Secondary to S.Pyogenes in Adolescents/Adults
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of APC 111 MP Tablet, 775 mg tablet, given orally (PO)once daily (QD) for 10 days compared to that of Penicillin VK, 250 mg PO four times daily (QID) for 10 days in terms of bacteriological outcome at the Test-of-Cure (TOC) Visit (Day 14-18) in the eligible Per-Protocol bacteriological (PPb) population.
Study identification
- NCT ID
- NCT00242281
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2006 (Type not available)
- Last update posted
- Oct 25, 2006
2005 – 2006
United States locations
- U.S. sites
- 35
- U.S. states
- 22
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Tallassee | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Carmichael | California | — | — |
| Not listed | Laguna Niguel | California | — | — |
| Not listed | San Luis Obispo | California | — | — |
| Not listed | Littleton | Colorado | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Conyers | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Overland Park | Kansas | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Wichitia | Kansas | — | — |
| Not listed | Bardstown | Kentucky | — | — |
| Not listed | Milford | Massachusetts | — | — |
| Not listed | New Bedford | Massachusetts | — | — |
| Not listed | Kalamazoo | Michigan | — | — |
| Not listed | Butte | Montana | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Johnson City | New York | — | — |
| Not listed | Burlington | North Carolina | — | — |
| Not listed | Simpsonville | North Carolina | — | — |
| Not listed | Canfield | Ohio | — | — |
| Not listed | North Wales | Pennsylvania | — | — |
| Not listed | Scotland | Pennsylvania | — | — |
| Not listed | Shippensburg | Pennsylvania | — | — |
| Not listed | Bristol | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Bountiful | Utah | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | West Jordan | Utah | — | — |
| Not listed | Newport News | Virginia | — | — |
| Not listed | Edmonds | Washington | — | — |
| Not listed | Wenatchee | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00242281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 25, 2006 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00242281 live on ClinicalTrials.gov.